Amneal Gets Del. Judge To Invalidate Estrogen Patch IP
Delaware's chief judge has invalidated claims of three patents covering Noven Pharmaceuticals' Minivelle estrogen patch for not meeting enablement and written description requirements, in a win for accused infringer Amneal Pharmaceuticals....To view the full article, register now.
Already a subscriber? Click here to view full article